Canada · Delayed Price · Currency is CAD Cheelcare Statistics
Total Valuation
Cheelcare has a market cap or net worth of CAD 31.60 million. The enterprise value is 31.36 million.
| Market Cap | 31.60M |
| Enterprise Value | 31.36M |
Important Dates
The next estimated earnings date is Thursday, December 24, 2026.
| Earnings Date | Dec 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Cheelcare has 22.73 million shares outstanding. The number of shares has increased by 63.09% in one year.
| Current Share Class | 22.73M |
| Shares Outstanding | 22.73M |
| Shares Change (YoY) | +63.09% |
| Shares Change (QoQ) | -0.91% |
| Owned by Insiders (%) | 15.07% |
| Owned by Institutions (%) | 1.61% |
| Float | 19.30M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.62 |
| PB Ratio | 12.03 |
| P/TBV Ratio | 12.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 13.52 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.63, with a Debt / Equity ratio of 0.83.
| Current Ratio | 3.63 |
| Quick Ratio | 2.58 |
| Debt / Equity | 0.83 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.81 |
| Interest Coverage | -8.68 |
Financial Efficiency
Return on equity (ROE) is -189.10% and return on invested capital (ROIC) is -46.88%.
| Return on Equity (ROE) | -189.10% |
| Return on Assets (ROA) | -39.07% |
| Return on Invested Capital (ROIC) | -46.88% |
| Return on Capital Employed (ROCE) | -56.13% |
| Weighted Average Cost of Capital (WACC) | 4.77% |
| Revenue Per Employee | 110,451 |
| Profits Per Employee | -177,637 |
| Employee Count | 22 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.33 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.63% in the last 52 weeks. The beta is 0.02, so Cheelcare's price volatility has been lower than the market average.
| Beta (5Y) | 0.02 |
| 52-Week Price Change | +61.63% |
| 50-Day Moving Average | 1.49 |
| 200-Day Moving Average | 1.53 |
| Relative Strength Index (RSI) | 38.75 |
| Average Volume (20 Days) | 7,488 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Cheelcare had revenue of CAD 2.32 million and -3.73 million in losses. Loss per share was -0.18.
| Revenue | 2.32M |
| Gross Profit | 733,375 |
| Operating Income | -2.52M |
| Pretax Income | -3.73M |
| Net Income | -3.73M |
| EBITDA | -2.51M |
| EBIT | -2.52M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 2.42 million in cash and 2.19 million in debt, with a net cash position of 232,894 or 0.01 per share.
| Cash & Cash Equivalents | 2.42M |
| Total Debt | 2.19M |
| Net Cash | 232,894 |
| Net Cash Per Share | 0.01 |
| Equity (Book Value) | 2.63M |
| Book Value Per Share | 0.12 |
| Working Capital | 2.97M |
Cash Flow
In the last 12 months, operating cash flow was -2.53 million and capital expenditures -181,541, giving a free cash flow of -2.71 million.
| Operating Cash Flow | -2.53M |
| Capital Expenditures | -181,541 |
| Depreciation & Amortization | 6,424 |
| Net Borrowing | 569,128 |
| Free Cash Flow | -2.71M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 31.62%, with operating and profit margins of -108.61% and -160.83%.
| Gross Margin | 31.62% |
| Operating Margin | -108.61% |
| Pretax Margin | -160.83% |
| Profit Margin | -160.83% |
| EBITDA Margin | -108.33% |
| EBIT Margin | -108.61% |
| FCF Margin | n/a |
Dividends & Yields
Cheelcare does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -63.09% |
| Shareholder Yield | -63.09% |
| Earnings Yield | -11.81% |
| FCF Yield | -8.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 16, 2025. It was a reverse split with a ratio of 0.3333333.
| Last Split Date | Jul 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.3333333 |
Scores
Cheelcare has an Altman Z-Score of 2.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.67 |
| Piotroski F-Score | 2 |